ATE182137T1 - Peptidylderivate als inhibitoren von metalloproteinase - Google Patents
Peptidylderivate als inhibitoren von metalloproteinaseInfo
- Publication number
- ATE182137T1 ATE182137T1 AT94913709T AT94913709T ATE182137T1 AT E182137 T1 ATE182137 T1 AT E182137T1 AT 94913709 T AT94913709 T AT 94913709T AT 94913709 T AT94913709 T AT 94913709T AT E182137 T1 ATE182137 T1 AT E182137T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- inhibitors
- derivatives
- metalloproteinase
- sec
- Prior art date
Links
- 102000005741 Metalloproteases Human genes 0.000 title 1
- 108010006035 Metalloproteases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000013382 Gelatinases Human genes 0.000 abstract 2
- 108010026132 Gelatinases Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 102000029816 Collagenase Human genes 0.000 abstract 1
- 108060005980 Collagenase Proteins 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229960002424 collagenase Drugs 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003475 metalloproteinase inhibitor Substances 0.000 abstract 1
- 125000001151 peptidyl group Chemical group 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/38—Eight-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939308696A GB9308696D0 (en) | 1993-04-27 | 1993-04-27 | Peptidyl derivatives |
ZA948169A ZA948169B (en) | 1993-04-27 | 1994-10-18 | Peptidyl derivatives and processes for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE182137T1 true ATE182137T1 (de) | 1999-07-15 |
Family
ID=26302820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94913709T ATE182137T1 (de) | 1993-04-27 | 1994-04-27 | Peptidylderivate als inhibitoren von metalloproteinase |
Country Status (10)
Country | Link |
---|---|
US (1) | US5714491A (de) |
EP (1) | EP0648205B1 (de) |
JP (1) | JPH08500124A (de) |
AT (1) | ATE182137T1 (de) |
AU (1) | AU6575394A (de) |
CA (1) | CA2139128A1 (de) |
DE (1) | DE69419473T2 (de) |
ES (1) | ES2134939T3 (de) |
WO (1) | WO1994025434A1 (de) |
ZA (1) | ZA948169B (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
GB2315750B (en) * | 1994-01-22 | 1998-07-01 | British Biotech Pharm | Metalloproteinase inhibitors |
JP3827324B2 (ja) * | 1994-01-22 | 2006-09-27 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
DE69615058T2 (de) | 1995-11-23 | 2002-06-27 | British Biotech Pharm | Metalloproteinase inhibitoren |
US6500948B1 (en) | 1995-12-08 | 2002-12-31 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
ATE225343T1 (de) * | 1995-12-20 | 2002-10-15 | Hoffmann La Roche | Matrix-metalloprotease inhibitoren |
WO1997031892A1 (fr) * | 1996-03-01 | 1997-09-04 | Sankyo Company, Limited | Derives d'acide hydroxamique |
US6037138A (en) * | 1996-04-26 | 2000-03-14 | The Children's Medical Center Corp. | Enzyme screen for breast cancer |
US6811995B1 (en) | 1996-04-26 | 2004-11-02 | Children's Medical Center Corporation | Non-invasive enzyme screen for cancer |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
ATE220660T1 (de) | 1996-09-10 | 2002-08-15 | British Biotech Pharm | Cytostatische hydroxamsäurederivate |
US6174915B1 (en) | 1997-03-25 | 2001-01-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6008243A (en) * | 1996-10-24 | 1999-12-28 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use |
US20020099004A1 (en) * | 1996-12-06 | 2002-07-25 | Lund Leif Roge | Inhibition of invasive remodelling |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
WO1998039024A1 (en) * | 1997-03-03 | 1998-09-11 | Darwin Discovery Limited | Selective mmp inhibitors having reduced side-effects |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
GB9707333D0 (en) | 1997-04-11 | 1997-05-28 | British Biotech Pharm | Metalloproteinase inhibitors |
WO1999021583A1 (en) * | 1997-10-29 | 1999-05-06 | Warner-Lambert Company | Method of inhibiting metastases of cancer cells |
NZ504683A (en) | 1998-01-09 | 2002-06-28 | Pfizer | Amide derivatives and pharmaceutical compositions thereof and their use as matrix metalloprotease inhibitors |
GB9803005D0 (en) | 1998-02-12 | 1998-04-08 | British Biotech Pharm | Anti-inflammatory agents |
US6329418B1 (en) | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
US6696456B1 (en) * | 1999-10-14 | 2004-02-24 | The Procter & Gamble Company | Beta disubstituted metalloprotease inhibitors |
CA2404131A1 (en) | 2000-03-21 | 2001-09-27 | The Procter & Gamble Company | Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
WO2001070693A2 (en) * | 2000-03-21 | 2001-09-27 | The Procter & Gamble Company | Difluorobutyric acid derivatives and their use as metalloprotease inhibitors |
CA2403778A1 (en) * | 2000-03-21 | 2001-09-27 | The Procter & Gamble Company | Carbocyclic side chain containing metalloprotease inhibitors |
PT1406893E (pt) | 2001-06-15 | 2007-07-12 | Vicuron Pharm Inc | Compostos bicíclicos de pirrolidina |
AR036053A1 (es) | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
US20040192658A1 (en) * | 2002-12-27 | 2004-09-30 | Angiotech International Ag | Compositions and methods of using collajolie |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8919251D0 (en) * | 1989-08-24 | 1989-10-04 | British Bio Technology | Compounds |
HUT61973A (en) * | 1990-12-03 | 1993-03-29 | Celltech Ltd | Process for producing peptidyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient |
-
1994
- 1994-04-27 AT AT94913709T patent/ATE182137T1/de not_active IP Right Cessation
- 1994-04-27 AU AU65753/94A patent/AU6575394A/en not_active Abandoned
- 1994-04-27 DE DE69419473T patent/DE69419473T2/de not_active Expired - Fee Related
- 1994-04-27 JP JP6524026A patent/JPH08500124A/ja active Pending
- 1994-04-27 US US08/356,315 patent/US5714491A/en not_active Expired - Fee Related
- 1994-04-27 CA CA002139128A patent/CA2139128A1/en not_active Abandoned
- 1994-04-27 EP EP94913709A patent/EP0648205B1/de not_active Expired - Lifetime
- 1994-04-27 WO PCT/GB1994/000895 patent/WO1994025434A1/en active IP Right Grant
- 1994-04-27 ES ES94913709T patent/ES2134939T3/es not_active Expired - Lifetime
- 1994-10-18 ZA ZA948169A patent/ZA948169B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES2134939T3 (es) | 1999-10-16 |
AU6575394A (en) | 1994-11-21 |
DE69419473T2 (de) | 2000-03-16 |
DE69419473D1 (de) | 1999-08-19 |
EP0648205A1 (de) | 1995-04-19 |
CA2139128A1 (en) | 1994-11-10 |
WO1994025434A1 (en) | 1994-11-10 |
EP0648205B1 (de) | 1999-07-14 |
ZA948169B (en) | 1996-04-18 |
US5714491A (en) | 1998-02-03 |
JPH08500124A (ja) | 1996-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69419473D1 (de) | Peptidylderivate als inhibitoren von metalloproteinase | |
NZ516562A (en) | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
TR200102499T2 (tr) | Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi | |
NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
ATE230757T1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
DK0728144T3 (da) | Peptidylforbindelser og deres terapeutiske anvendelse som inhibitorer af metalloproteinaser | |
ATE233738T1 (de) | Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten | |
DE69624262T2 (de) | Sulfonamidinhibitoren von matrix metalloproteinasen | |
NO308794B1 (no) | Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse | |
DE69111077T2 (de) | Chinazolinderivate um die antitumorwirkung zu verbessern. | |
AP2001002318A0 (en) | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
TR199800818A2 (xx) | �kame edilmi� diaminokarbonik asitler. | |
DE69022150D1 (de) | Neue Peptidasen und Isomerasen-Inhibitoren. | |
HUP9802971A1 (hu) | Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére | |
DE69811111D1 (de) | Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung | |
NO972391L (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
NZ331484A (en) | Serine protease inhibitors having an alkynylamino side chain for use in treatment of thrombin related diseases | |
DE69935853D1 (de) | Anwendung von alfa1beta1 integrinrezeptorinhibitoren und tgf-beta1-inhibitoren zur behandlung von nierenkrankheiten | |
YU49422B (sh) | Upotreba inhibitora ugljenične anhidraze za proizvodnju medikamenata za tretiranje makularnog edema ili makularne degeneracije izazvane starošću | |
DE60033809D1 (de) | Inhibitoren von metalloproteinasen | |
DE69912743D1 (de) | Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges | |
TR200000954T2 (tr) | Mikrodolaşım hastalıklarının tedavisi ve önlenmesi için madde. | |
LV11593A (lv) | Dimetikona pielietojums aizcietejumu arstesana | |
DK1042288T3 (da) | Tripeptidyl-peptidase inhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |